Literature DB >> 9568776

Percutaneous cystolithotomy after augmentation cystoplasty: comparison with open procedures.

S G Docimo1, C R Orth, P G Schulam.   

Abstract

Percutaneous procedures for the removal of calculi from reconstructed bladders have not been compared in a single institution with traditional open methods. The records of patients undergoing seven percutaneous and six open procedures for the removal of calculi from augmented bladders were reviewed. Operative time, hospitalization time, complications, stone burden, and recurrence were compared. All patients were stone-free at the end of either one or two procedures. Four of six patients in the percutaneous group and four of six patients in the open group had recurrent bladder calculi during average follow-up of 30 months. The average hospital stay was 1.1 days for patients undergoing percutaneous procedures and 3.7 days for those undergoing open cystolithotomy. Narcotic use was significantly lower in the percutaneous group. Percutaneous cystolithotomy is safe, effective, and currently the preferred method for removing stones from an augmented bladder.

Entities:  

Mesh:

Year:  1998        PMID: 9568776

Source DB:  PubMed          Journal:  Tech Urol        ISSN: 1079-3259


  4 in total

Review 1.  Urolithiasis in enterocystoplasties.

Authors:  Christopher R J Woodhouse; William G Robertson
Journal:  World J Urol       Date:  2004-09-03       Impact factor: 4.226

Review 2.  Surgical management of urolithiasis in spinal cord injury patients.

Authors:  Philippe Nabbout; Gennady Slobodov; Daniel J Culkin
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

3.  [Giant calculi on enterocystoplasty].

Authors:  Khalid Elmortaji; Ghassane Elomri; Saad Bennani; Redouane Rabii; Rachid Aboutaib; Fethi Meziane
Journal:  Pan Afr Med J       Date:  2014-12-08

4.  Concurrent stone stabilization improves ultrasonic and pneumatic efficacy during cystolithopaxy: an in vitro analysis.

Authors:  Shubha De; Carl Sarkissian; Giovanni Marchinni; Manoj Monga
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.